Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 43
Electric Media R&D specialized in Audit, Technical Audit, and Cost Audit, third party Audit of AMC Annual Maintenance Contractor in Mumbai. Electric Media R&D specialized in Inspection, Physical Inspection, Technical Inspection, Third Party Inspection of AMC Annual Maintenance Contractor in Mumbai. Elect...
A critical implementation lesson learned was the recognition that in order to achieve the best performance of SSO technology, migration to the cloud and a virtual desktop with a thin client should be considered before implementation. In these 19 hospitals, SSO is an effective and highly cost-effec...
TD Insurance Multi-Trip Medical Plan could be more cost-effective than purchasing a single trip plan multiple times. Explore this plan.
Data include the use of FINTEPLA®▼(fenfluramine)1,2 in seizures associated with Dravet syndrome and Lennox-Gastaut syndrome, BRIVIACT® (brivaracetam)3,4 and VIMPAT® (lacosamide)5,6 in focal-onset seizures, and *Staccato® alprazolam7 (investigational...
“We launched this registry in 2010 to evaluate and better understand how our family of aortic devices perform in real-world applications, and as a reflection of our continued commitment to advancing patient care in the treatment of aortic disease,” said Eric Zacharias, Vascular Business Leader....
During the financial year, the Board approved the proposed acquisition of Vifor Pharma, a global pharmaceutical company focusing on the treatment areas of iron deficiency, dialysis, nephrology and rare disease. Through this acquisition, our global reach, R&D capabilities, and balance sheet will help ...
cost of development of Disc’s product candidates; Disc’s plans to research, develop and commercialize its current and future product candidates; the timing of initiation of Disc’s planned preclinical studies and clini...
Takashi AkibaCongress President, 31st Annual Meeting of Japanese Society for Apheresis, Professor, Department of Blood Purification, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan, Email: takiba@kc.twmu.ac.jpJohn Wiley & Sons, LtdTherapeutic Apheresis and Dialysis...
Treatment (tx) failure: persistent erythema, tenderness, and/or draining lesions. New lesion: primary resolution with development of an abscess at a different location. Compliance was evaluated by the return of the study medication or by pt report. Results: One hundred and sixty-one patients ...